Vivos Therapeutics Expands AI Platform Deployment with Greenway Health — Vivos Therapeutics, Inc.

Event summary

Vivos Therapeutics is expanding its partnership with Greenway Health to deploy the AI-enabled Novare platform across all clinical and revenue operations.
Greenway estimates the implementation could generate up to $9.1 million in annual value for Vivos at Sleep Centers of Nevada, including $8.0 million from increased patient capacity and $1.0 million from revenue-cycle improvements.
Vivos expects to save an additional $1.8 million annually from recovered labor hours and create capacity for nearly 30,000 additional patient visits.
The deployment is part of Vivos' broader strategy to apply technology and automation across its growing healthcare platform.

The big picture

Vivos Therapeutics is positioning itself as an early adopter of AI in the sleep medicine sector, aiming to improve both patient care and financial performance. This strategic move comes as healthcare providers face rising labor costs and administrative burdens, making operational efficiency a key competitive advantage. The deployment of Greenway's Novare platform could set a precedent for how AI is integrated into clinical and revenue operations across the industry.

What we're watching

Operational Leverage: How Vivos' AI-driven platform will affect its ability to scale operations efficiently as it expands into new markets like Arizona and Florida.
Revenue Cycle Improvements: Whether the AI-enabled automation can sustain the projected $1.0 million in annual revenue-cycle improvements and reduce claim denials by up to 20%.
Market Adoption: The pace at which other sleep medicine providers adopt similar AI technologies, potentially setting a new industry standard.